Extensively Drug-resistant tuberculosis in South Korea

Distinguished Speakers Series Presents:

Clifton Barry, III, PhD
Senior Investigator, Chief, Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases

"Extensively Drug-resistant tuberculosis in South Korea"

Wednesday, November 18, 2009
3:00-5:00PM

To RSVP, please click here.

 Joseph B. Martin Conference Center at HMS
The Pechet Room
77 Avenue Louis Pasteur 
Boston, MA 02115

Dr. Barry's talk will be followed by a networking reception.

Dr. Clifton E. Barry, III, received his Ph.D. in organic and bioorganic chemistry in 1989 from Cornell University, studying the biosynthesis of complex natural products. Following postdoctoral research at Johns Hopkins University, he joined NIAID's Rocky Mountain Laboratories. In 1998, he was tenured as chief of the Tuberculosis Research Section (TBRS) and relocated his laboratory to the NIH main campus in Maryland. He is principle investigator on several overseas clinical trials studying tuberculosis and anti-tuberculosis chemotherapy in Korea, China and Nigeria. Dr. Barry is a member of several editorial boards and has authored more than 120 research publications in tuberculosis since entering the field 16 years ago. In 2009 he was named by ScienceWatch as the most highly cited researcher working in the field of Tuberculosis.